bibliographic entry 7573951 [be/7573951]
https://w3id.org/oc/corpus/be/7573951

is a

• bibliographic reference

content

• Zinman, B, Inzucchi, SE, Lachin, JM, Wanner, C, Ferrari, R, Fitchett, D, Bluhmki, E, Hantel, S, Kempthorne-Rawson, J, Newman, J, Johansen, OE, Woerle, HJ, Broedl, UC. Rationale, design, and baseline characteristics of a randomized, placebo-controlled cardiovascular outcome trial of empagliflozin (EMPA-REG OUTCOME™). Cardiovasc Diabetol 2014; 13: 102. PMID: 24943000

references

• https://w3id.org/oc/corpus/br/3217306